Elevance Health Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $435.58
- Today's High:
- $448.125
- Open Price:
- $446
- 52W Low:
- $437.5557
- 52W High:
- $546.4424
- Prev. Close:
- $449.26
- Volume:
- 1206376
Company Statistics
- Market Cap.:
- $112.87 billion
- Book Value:
- 157.544
- Revenue TTM:
- $160.68 billion
- Operating Margin TTM:
- 5.62%
- Gross Profit TTM:
- $40.11 billion
- Profit Margin:
- 3.87%
- Return on Assets TTM:
- 5.39%
- Return on Equity TTM:
- 16.99%
Company Profile
Elevance Health Inc had its IPO on 2001-01-02 under the ticker symbol ELV.
The company operates in the Healthcare sector and Healthcare Plans industry. Elevance Health Inc has a staff strength of 102,300 employees.
Stock update
Shares of Elevance Health Inc opened at $446 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $435.58 - $448.13, and closed at $445.3.
This is a -0.88% slip from the previous day's closing price.
A total volume of 1,206,376 shares were traded at the close of the day’s session.
In the last one week, shares of Elevance Health Inc have increased by +1%.
Elevance Health Inc's Key Ratios
Elevance Health Inc has a market cap of $112.87 billion, indicating a price to book ratio of 3.4516 and a price to sales ratio of 0.7729.
In the last 12-months Elevance Health Inc’s revenue was $160.68 billion with a gross profit of $40.11 billion and an EBITDA of $10.21 billion. The EBITDA ratio measures Elevance Health Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Elevance Health Inc’s operating margin was 5.62% while its return on assets stood at 5.39% with a return of equity of 16.99%.
In Q1, Elevance Health Inc’s quarterly earnings growth was a positive 13.4% while revenue growth was a positive 10.7%.
Elevance Health Inc’s PE and PEG Ratio
- Forward PE
- 15.8983
- Trailing PE
- 18.2154
- PEG
- 1.3844
Its diluted EPS in the last 12-months stands at $26.14 per share while it has a forward price to earnings multiple of 15.8983 and a PEG multiple of 1.3844. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Elevance Health Inc’s profitability.
Elevance Health Inc stock is trading at a EV to sales ratio of 0.9079 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.7729.
Elevance Health Inc stock pays annual dividends of $5.32 per share, indicating a yield of 1.27% and a payout ratio of 18.24%.
Balance sheet and cash flow metrics
- Total Assets
- $109.04 billion
- Total Liabilities
- $41.89 billion
- Operating Cash Flow
- $-3184000000.00
- Capital Expenditure
- $301 million
- Dividend Payout Ratio
- 18.24%
Elevance Health Inc ended 2024 with $109.04 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $109.04 billion while shareholder equity stood at $37.36 billion.
Elevance Health Inc ended 2024 with $2.03 billion in deferred long-term liabilities, $41.89 billion in other current liabilities, 2000000.00 in common stock, $30.71 billion in retained earnings and $25.27 billion in goodwill. Its cash balance stood at $10.14 billion and cash and short-term investments were $10.14 billion. The company’s total short-term debt was $265,000,000 while long-term debt stood at $25.20 billion.
Elevance Health Inc’s total current assets stands at $59.82 billion while long-term investments were $6.75 billion and short-term investments were $27.64 billion. Its net receivables were $16.71 billion compared to accounts payable of $20.60 billion and inventory worth $0.
In 2024, Elevance Health Inc's operating cash flow was $-3184000000.00 while its capital expenditure stood at $301 million.
Comparatively, Elevance Health Inc paid $0.18 in dividends in 2024.
Other key metrics
- Current Trading Price
- $445.3
- 52-Week High
- $546.4424
- 52-Week Low
- $437.5557
- Analyst Target Price
- $573.45
Elevance Health Inc stock is currently trading at $445.3 per share. It touched a 52-week high of $546.4424 and a 52-week low of $546.4424. Analysts tracking the stock have a 12-month average target price of $573.45.
Its 50-day moving average was $454.43 and 200-day moving average was $468.56 The short ratio stood at 1.71 indicating a short percent outstanding of 0%.
Around 21.3% of the company’s stock are held by insiders while 9274.7% are held by institutions.
Frequently Asked Questions About Elevance Health Inc
Similar Industry Stocks (Healthcare Plans)
Most Active
Top Gainers
Top Losers
About
Elevance Health, Inc. operates as a health benefits company. The company operates through four segments: Commercial & Specialty Business, Government Business, CarelonRx, and Other. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was founded in 1944 and is based in Indianapolis, Indiana.